CORC  > 暨南大学
Characteristics of the TCR Vβ repertoire in imatinib-resistant chronic myeloid leukemia patients with ABL mutations
XU Ling[1]; LU Yu Hong[2]; LAI Jing[1,2]; YU Wei[3]; ZHANG Yi Kai[1]; JIN Zhen Yi[1]; XU Yan[1,4]; CHEN Jie[2]; ZHA Xian Feng[5]; CHEN Shao Hua[1]
2015
卷号0期号:12页码:1276
关键词慢性粒细胞白血病 TCR 患者 突变 耐药 ABL 反转录聚合酶链反应 T细胞受体
URL标识查看原文
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/4742566
专题暨南大学
作者单位1.[1]Institute of Hematology, Jinan University, Guangzhou 510632, China
2.[2]Department of Hematology, First Affiliated Hospital, Jinan University, Guangzhou 510632, China
3.[3]Department of Hematology, Guangzhou No. 12 People's Hospital, Guangzhou 510632, China
4.[4]Key Laboratory for Regenerative Medicine of Ministry of Education, Jinan University, Guangzhou 510632, China
5.[5]Department of clinical laboratory, First Affiliated Hospital, Jinan University, Guangzhou 510632, China
推荐引用方式
GB/T 7714
XU Ling[1],LU Yu Hong[2],LAI Jing[1,2],et al. Characteristics of the TCR Vβ repertoire in imatinib-resistant chronic myeloid leukemia patients with ABL mutations[J],2015,0(12):1276.
APA XU Ling[1].,LU Yu Hong[2].,LAI Jing[1,2].,YU Wei[3].,ZHANG Yi Kai[1].,...&LI Yang Qiu[1,2,4].(2015).Characteristics of the TCR Vβ repertoire in imatinib-resistant chronic myeloid leukemia patients with ABL mutations.,0(12),1276.
MLA XU Ling[1],et al."Characteristics of the TCR Vβ repertoire in imatinib-resistant chronic myeloid leukemia patients with ABL mutations".0.12(2015):1276.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace